We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative Laser Improves Cataract Surgery Outcomes

By HospiMedica International staff writers
Posted on 27 Nov 2012
Two new studies suggest that femtosecond laser systems may provide improvements in outcomes for cataract surgery.

Researchers at of the University of Sydney (NSW, Australia) conducted a retrospective review of 500 single-surgeon cases using the LenSx system, comparing safety parameters with those seen in the published literature on manual surgery. More...
The researchers found that the rate of anterior radial tears was 0.2% versus 0.79%-5.6% in manual surgery controls. Additionally, there was no evidence of posterior capsule tears or posterior lens dislocation, versus a range of 0.45%-2.09% for posterior capsule tears and 0%-0.12% for posterior lens dislocation in the manual controls.

In terms of complications that lacked a comparison with manual surgery, the researchers found low rates of suction breaks, manual corneal incisions, pupillary constriction, and anterior capsule tags. A subgroup of patients that had both visual and refractive surgery--141 of whom had laser surgery and 57 of whom had manual--showed no significant differences in a number of visual and refractive outcomes three months after surgery. The study was presented as an oral session by Michael Lawless, MD, at the American Academy of Ophthalmology (AAO) annual meeting, held during November 2012 in Chicago (IL, USA).

In a second study, researchers at the Ruhr University Eye Hospital Bochum (Germany), reported their experience with 850 cases using the Catalys femtosecond laser. The researchers found that compared with manual surgery, laser surgery offered a more precise capsulotomy size and shape, as well as less capsular bag shrinkage (9.9 mm versus 9.6 mm). Postoperative inflammation was reduced by about 19% with femtosecond laser surgery by day one, and best-corrected visual acuity was also better in the early period of up to 2 months. The study was presented at the same AAO session by Burkhard Dick, MD.

Femtosecond lasers emit optical pulses with a duration well below 1 picosecond, in the domain of femtoseconds (1 fs = 10−15 s). The lasers are used in cataract and refractive vision correction surgery, and have been available on the market since 2011, starting with the LenSx system, a product of Alcon (Fort Worth, TX, USA), and followed by other devices including the Catalys system, a product of OptiMedica (Sunnyvale, CA, USA).

Related Links:

University of Sydney
Ruhr University Eye Hospital Bochum
Alcon




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.